Esomeprazole Magnesium Delayed Release Capsules USP — Class III drug recall D-1256-2020
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2020-05-06, distributed nationwide. Discoloration: product contains brown pellets
| Recall number | D-1256-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2020-04-24 |
| Classified | 2020-04-28 |
| Reported by FDA | 2020-05-06 |
| Terminated | 2022-05-13 |
| Distributed | Nationwide (US) |
| Quantity | 1,752 bottles |
| NDC | 43598-0509, 43598-0509-10, 43598-0509-30, 43598-0509-90, 43598-0510, 43598-0510-10, 43598-0510-30, 43598-0510-90 |
| Lot numbers | C900642 |
| Expiration dates | 2020-06 |
Product
Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA, NDC 43598-510-10
Reason for recall
Discoloration: product contains brown pellets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1256-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.